"10.1371_journal.pone.0144278","plos one","2015-12-04T00:00:00Z","Stéphanie Dizier; Jean-Marie Forel; Louis Ayzac; Jean-Christophe Richard; Sami Hraiech; Samuel Lehingue; Anderson Loundou; Antoine Roch; Claude Guerin; Laurent Papazian; ACURASYS study investigators; PROSEVA Study Group","Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, Réanimation des Détresses Respiratoires et des Infections Sévères, 13015, Marseille, France; Aix-Marseille Université, Faculté de médecine, URMITE UMR CNRS 7278, 13005, Marseille, France; Hospices Civils de Lyon, Hôpital Henri Gabrielle, CClin Sud Est, 69230, Saint Genis Aval, France; Hospices Civils de Lyon, Hôpital de la Croix-Rousse, Réanimation médicale et Surveillance Continue, 69004, Lyon, France; Unité dAide Méthodologique à la Recherche clinique DRRC/AP-HM, Laboratoire de Santé Publique Faculté de Médecine, 13005, Marseille, France","Conceived and designed the experiments: SD JMF CG LP. Performed the experiments: JCR SL CG SH. Analyzed the data: AL LA JMF LP SD. Wrote the paper: SD JMF AR LP.","The authors of this manuscript have read the journals policy and have the following competing interests: The authors declare that they have no conflict of interest relevant to this article to disclose. PROSEVA authors report several conflicts of interest. Dr. Guérin receiving grant support from Air Liquide; Dr. Mercat, receiving consulting fees from Faron Pharmaceuticals, grant support from Covidien and General Electric, patent royalties on a method for evaluating positive end-expiratory pressure that is licensed to General Electric, and reimbursement for travel expenses from Covidien and Maquet; Dr. Jaber, receiving consulting fees from Maquet and Dräger, lecture fees from Fisher and Paykel, Abbott Laboratories, and Philips Respironics, and reimbursement for travel expenses from Pfizer; and Dr. Mancebo, receiving fees for serving on the data and safety monitoring board of Air Liquide, consulting fees from Faron Pharmaceuticals, ALung, and Philips Respironics, and grant support to his institution from Covidien and General Electric. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","12","Stéphanie Dizier","SD",12,TRUE,4,4,5,4,TRUE,TRUE,TRUE,1,"12",TRUE
